Cost Savings Associated With Implementing 4 Total Joint Replacement Electronic Clinical Quality Measures Nationally: 2020-2040.
Journal
Journal of patient safety
ISSN: 1549-8425
Titre abrégé: J Patient Saf
Pays: United States
ID NLM: 101233393
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
20
11
2023
pubmed:
3
11
2023
entrez:
3
11
2023
Statut:
ppublish
Résumé
Digital transformation using widely available electronic data is a key component to improving health outcomes and customer choice and decreasing cost and measurement burden. Despite these benefits, existing information on the potential cost savings from electronic clinical quality measures (eCQMs) is limited. We assessed the costs of implementing 4 eCQMs related to total hip and/or total knee arthroplasty into electronic health record systems across healthcare systems in the United States. We used published literature and technical expert panel consultation to calculate low-, mid-, and high-range hip and knee arthroplasty surgery projections, and used empirical testing, literature, and technical expert panel consultation to develop an economic model to assess projected cost savings of eCQMs when implemented nationally. Low-, mid-, and high-range projected cost savings for year's 2020, 2030, and 2040 were calculated for 4 orthopedic eCQMs. Mid-range projected cost savings for 2020 ranged from $7.9 to $31.9 million per measure per year. A breakeven of between 0.5% and 5.1% of adverse events (measure dependent) must be averted for cost savings to outweigh implementation costs. All measures demonstrated potential cost savings. These findings suggest that eCQMs have the potential to lower healthcare costs and improve patient outcomes without adding to physician documentation burden. The Centers for Medicare and Medicaid Services' investment in eCQMs is an opportunity to reduce adverse outcomes and excess costs in orthopedics.
Sections du résumé
BACKGROUND
BACKGROUND
Digital transformation using widely available electronic data is a key component to improving health outcomes and customer choice and decreasing cost and measurement burden. Despite these benefits, existing information on the potential cost savings from electronic clinical quality measures (eCQMs) is limited.
METHODS
METHODS
We assessed the costs of implementing 4 eCQMs related to total hip and/or total knee arthroplasty into electronic health record systems across healthcare systems in the United States. We used published literature and technical expert panel consultation to calculate low-, mid-, and high-range hip and knee arthroplasty surgery projections, and used empirical testing, literature, and technical expert panel consultation to develop an economic model to assess projected cost savings of eCQMs when implemented nationally.
RESULTS
RESULTS
Low-, mid-, and high-range projected cost savings for year's 2020, 2030, and 2040 were calculated for 4 orthopedic eCQMs. Mid-range projected cost savings for 2020 ranged from $7.9 to $31.9 million per measure per year. A breakeven of between 0.5% and 5.1% of adverse events (measure dependent) must be averted for cost savings to outweigh implementation costs.
CONCLUSIONS
CONCLUSIONS
All measures demonstrated potential cost savings. These findings suggest that eCQMs have the potential to lower healthcare costs and improve patient outcomes without adding to physician documentation burden. The Centers for Medicare and Medicaid Services' investment in eCQMs is an opportunity to reduce adverse outcomes and excess costs in orthopedics.
Identifiants
pubmed: 37922248
doi: 10.1097/PTS.0000000000001171
pii: 01209203-990000000-00165
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
539-546Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors disclose no conflict of interest.
Références
Centers for Medicare and Medicaid Services. Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) funding opportunity: measure development for the quality payment program. . Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-Programs/MACRA-MIPS-and-APMs/9-21-18-MACRA-Measure-Funding-FAQs.pdf . Accessed October 10, 2021.
Centers for Medicare and Medicaid Services. CMS Quality Measurement Action Plan [PowerPoint presentation] 2021 CMS Quality Conference. Available at: https://www.cms.gov/files/document/2021-cms-quality-conference-cms-quality-measurement-action-plan-march-2021.pdf . Accessed March 3, 2021
Bozic KJ. Fifth AJRR Annual Report on Hip and Knee Arthroplasty Data . Rosemont, IL: American Joint Replacement Registry; 2018. Available at: https://connect.ajrr.net/hubfs/PDFs%20and%20PPTs/AAOS-AJRR%202018%20Annual%20Report-final.pdf . Accessed March 1 2021.
Haro-Gómez HL, Merida-Herrera E, Torres-Fernández BJ, et al. Preoperative serum albumin as a predictor of complications following total hip replacement in patients with rheumatoid arthritis. Acta Ortop Mex . 2018;32:193–197.
Namba RS, Inacio MCS, Paxton EW. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am . 2013;95:775–782.
Lieberman JR, Bell JA. Venous thromboembolic prophylaxis after total hip and knee arthroplasty. J Bone Joint Surg Am . 2021;103:1556–1564.
Stansby G, Donald I. Reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism in medical inpatients. Clin Med . 2019;19:100–103.
Cook DJ, Kaskovich SW, Pirkle SC, et al. Benchmarks of duration and magnitude of opioid consumption after total hip and knee arthroplasty: a database analysis of 69,368 patients. J Arthroplasty . 2019;34:638–644.e1.
Miskovic A, Lumb AB. Postoperative pulmonary complications. Br J Anaesth . 2017;118:317–334.
Hess SR, Lahaye LA, Waligora AC, et al. Safety and side-effect profile of intrathecal morphine in a diverse patient population undergoing total knee and hip arthroplasty. Eur J Orthop Surg Traumatol . 2019;29:125–129.
Schwinghammer AJ, Isaacs AN, Benner RW, et al. Continuous infusion ketorolac for postoperative analgesia following unilateral total knee arthroplasty. Ann Pharmacother . 2017;51:451–456.
Bozic K, Yu H, Zywiel MG, et al. Quality measure public reporting is associated with improved outcomes following hip and knee replacement. J Bone Joint Surg Am . 2020;102:1799–1806.
National Quality Forum. Hospital-level risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA). Available at: https://www.qualityforum.org/QPS/1550 . Accessed February 22, 2021.
National Quality Forum. Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS) Eligible Clinicians and Clinician Groups. Available at: https://www.qualityforum.org/QPS/3493 . Accessed February 22, 2021.
Collaborative RB. Washington State Agency Medical Directors’ Group. Prescribing Opioids for Postoperative Pain—Supplemental Guidance. Available at https://agencymeddirectors.wa.gov/Files/FinalSupBreeAMDG PostopPain091318wcover.pdf . Accessed February 1, 2021.
Canet J, Sabaté S, Mazo V, et al. Development and validation of a score to predict postoperative respiratory failure in a multicentre European cohort: a prospective, observational study. Eur J Anaesthesiol . 2015;32:458–470.
Fernandez-Bustamante A, Frendl G, Sprung J, et al. Postoperative pulmonary complications, early mortality, and hospital stay following noncardiothoracic surgery: a multicenter study by the perioperative research network investigators. JAMA Surg . 2017;152:157–166.
Mazo V, Sabate S, Canet J, et al. Prospective external validation of a predictive score for postoperative pulmonary complications. Anesthesiology . 2014;121:219–231.
Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res . 2011;11:135.
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest . 2012;141(2 suppl):e278S–e325S.
Kaushal R, Jha AK, Franz C, et al. Return on investment for a computerized physician order entry system. J Am Med Inform Assoc . 2006;13:261–266.
Bashinskaya B, Zimmerman RM, Walcott BP, et al. Arthroplasty utilization in the United States is predicted by age-specific population groups. ISRN Orthop . 2012;2012:1–8.
Inacio MCS, Paxton EW, Graves SE, et al. Projected increase in total knee arthroplasty in the United States–an alternative projection model. Osteoarthritis Cartilage . 2017;25:1797–1803.
Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am . 2007;89:780–785.
Kurtz SM, Ong KL, Lau E, et al. Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am . 2014;96:624–630.
Singh JA, Yu S, Chen L, et al. Rates of total joint replacement in the United States: future projections to 2020–2040 using the national inpatient sample. J Rheumatol . 2019;46:1134–1140.
Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am . 2018;100:1455–1460.
Valladares AF, Kilgore KM, Partridge J, et al. How a malnutrition quality improvement initiative furthers malnutrition measurement and care: results from a hospital learning collaborative. JPEN J Parenter Enteral Nutr . 2021;45:366–371.
Furukawa MF, Kimmey L, Jones DJ, et al. Consolidation of providers into health systems increased substantially, 2016–18: study examines provider consolidation into vertically-integrated health systems. Health Aff . 2020;39:1321–1325.
U.S. Bureau of Labor Statistics, Producer Price Index by Industry: General Medical and Surgical Hospitals [PCU622110622110], retrieved from FRED, Federal Reserve Bank of St. Louis. Available at: https://fred.stlouisfed.org/series/PCU622110622110 , Accesed August 9, 2021.
Culler SD, Jevsevar DS, Shea KG, et al. The incremental hospital cost and length-of-stay associated with treating adverse events among Medicare beneficiaries undergoing THA during fiscal year 2013. J Arthroplasty . 2016;31:42–48.
Bozic KJ, Grosso LM, Lin Z, et al. Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplasty. J Bone Joint Surg Am . 2014;96:640–647.
Schoenfeld AJ, Jiang W, Chaudhary MA, et al. Sustained prescription opioid use among previously opioid-naive patients insured through TRICARE (2006–2014). JAMA Surg . 2017;152:1175–1176.
Florence CS, Zhou C, Luo F, et al. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care . 2016;54:901–906.
Kessler ER, Shah M, Gruschkus SK, et al. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy . 2013;33:383–391.
Mantilla CB, Horlocker TT, Schroeder DR, et al. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology . 2002;96:1140–1146.
Li T, Curtin-Bowen M, Pullman A, et al. Testing of a risk standardized major bleeding and venous thromboembolism (VTE) electronic clinical quality measure (eCQM) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA). AMIA Annual Symposium Proceedings . 2021. AMIA Annu Symp Proc . 2022;2021:736–743.
Ollendorf DA, Vera-Llonch M, Oster G. Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients. Am J Health Syst Pharm . 2002;59:1750–1754.
Almegren MO, Alhedaithy AA, Alomri AS, et al. Venous thromboembolism after total knee and hip arthroplasty: a retrospective study. Saudi Med J . 2018;39:1096–1101.
Halawi MJ, Jongbloed W, Baron S, et al. Patient dissatisfaction after primary total joint arthroplasty: the patient perspective. J Arthroplasty . 2019;34:1093–1096.
Belmont PJ Jr., Goodman GP, Hamilton W, et al. Morbidity and mortality in the thirty-day period following total hip arthroplasty: risk factors and incidence. J Arthroplasty . 2014;29:2025–2030.
Salmon P, Hall GM, Peerbhoy D, et al. Recovery from hip and knee arthroplasty: patients' perspective on pain, function, quality of life, and well-being up to 6 months postoperatively. Arch Phys Med Rehabil . 2001;82:360–366.
Ravi B, Croxford R, Reichmann WM, et al. The changing demographics of total joint arthroplasty recipients in the United States and Ontario from 2001 to 2007. Best Pract Res Clin Rheumatol . 2012;26:637–647.
Wolford ML, Palso K, Bercovitz A. Hospitalization for total hip replacement among inpatients aged 45 and over: United States, 2000–2010. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2015.
Centers for Medicare & Medicaid Services [Internet] . Baltimore, MD: Electronic Clinical Quality Measures Basics; 2021. Updated February 18, 2021. Available at: https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/ClinicalQualityMeasures#:~:text=Electronic%20clinical%20quality%20measures%20(eCQMs,electronic%20health%20record%20(EHR).&text = Efficient%20Use%20of%20Healthcare%20Resources . Accessed February 24, 2021.
CMS Measures Inventory Tool (2021) Search: “eCQM”. Available at: https://cmitcmsgov/CMIT_public/ListMeasures?strutstokenname=token&token=2BBIEBF5W0JF7G0DM1W9WQ6BU3AH2TEJ&filters=Status_untok%7Cd%7CActive&view=&makeStick=&wasSearchSubmitted=true&q=ecqm . Accessed March 3, 2022.
United States Census Bureau. 65 and older population grows rapidly as baby boomers age. Press Release. Available at: https://www.census.gov/newsroom/press-releases/2020/65-older-population-grows.html . Accessed October 1, 2021.
Hales CM, Carroll MD, Fryar CD, et al. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017–2018. NCHS Data Brief, No 360 . Hyattsville, MD: National Center for Health Statistics:2020.
Changulani M, Kalairajah Y, Peel T, et al. The relationship between obesity and the age at which hip and knee replacement is undertaken. J Bone Joint Surg Br . 2008;90:360–363.
Keating D, Johnson A, Ulmanu M. The pandemic marks another grim milestone: 1 in 500 Americans have died of covid-19. The Washington Post. 15 September 2021. Accessed at: https://www.washingtonpost.com/health/interactive/2021/1-in-500-covid-deaths/ . Accessed September 23, 2023.
Barnes CL, Zhang X, Stronach BM, et al. The initial impact of COVID-19 on total hip and knee arthroplasty. J Arthroplasty . 2021;36:S56–S61.